Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%). We observed no increase in the seroprevalence trend after widespread school reopening....

Descripción completa

Detalles Bibliográficos
Autores principales: Falender, Rebecca A., Mitchell, Paul G., Guzman-Cottrill, Judith A., Cieslak, Paul R., Sutton, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852/
https://www.ncbi.nlm.nih.gov/pubmed/37486347
http://dx.doi.org/10.3201/eid2908.230471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852/
https://www.ncbi.nlm.nih.gov/pubmed/37486347
http://dx.doi.org/10.3201/eid2908.230471

Ejemplares similares